慢性肢体威胁性缺血合并慢性肾脏病患者下肢旁路术与外周血管介入治疗的死亡率和截肢率比较
本研究基于血管质量倡议(VQI)与医疗保险索赔链接数据,采用倾向评分1:1匹配比较下肢旁路术(LEB)与外周血管介入(PVI)在合并慢性肾脏病(CKD)的慢性肢体威胁性缺血(CLTI)患者中的结局。共匹配4084例(每组2042例),结果显示无论CKD状态如何,LEB与PVI的30天死亡率相似,但LEB与较低的30天截肢风险相关;LEB与较低的5年死亡率相关,而5年截肢率无差异;CKD状态未改变上述结果。
要点
- 无论CKD状态如何,LEB与PVI的30天死亡率相似(HR 0.94,95%CI 0.63-1.42,P=.78)。
- LEB与较低的30天截肢风险相关(sHR 0.66,95%CI 0.44-0.97,P=.04),CKD状态未改变此结果。
- LEB与较低的5年死亡率相关(HR 0.79,95%CI 0.71-0.88,P<.001),5年截肢率无差异(sHR 1.03,95%CI 0.89-1.20,P=.67)。
核心结论
- 无论CKD状态如何,与PVI相比,LEB与较低的5年全因死亡风险和30天截肢风险相关。
- 研究结果可能有助于为CLTI合并CKD患者(常被认为手术风险过高)的LEB与PVI偏好敏感治疗决策提供信息。
研究设计与样本
- 从血管质量倡议(VQI)中查询接受LEB和PVI的患者,并链接医疗保险索赔结局数据。
- 使用13个变量计算倾向评分,采用1:1匹配方法,共纳入4084例患者(每组2042例)。
- 采用Kaplan-Meier和Cox比例风险模型评估30天和5年死亡率,并加入CKD交互项;截肢分析采用累积 Incidence 函数和Fine-Gray模型处理竞争风险,并加入CKD交互项。
主要发现
- 匹配队列平均年龄71.0±10.8岁,男性占69.0%。
- 无论CKD状态如何,LEB与PVI的30天死亡率相似(HR 0.94,95%CI 0.63-1.42,P=.78)。
- LEB与较低的30天截肢风险相关(sHR 0.66,95%CI 0.44-0.97,P=.04),CKD状态未改变此结果。
- LEB与较低的5年死亡率相关(HR 0.79,95%CI 0.71-0.88,P<.001),但5年截肢率无差异(sHR 1.03,95%CI 0.89-1.20,P=.67),CKD状态未改变这些结果。
关键数值与推荐
- 30天死亡率:LEB vs PVI的HR 0.94(95%CI 0.63-1.42,P=.78)。
- 30天截肢率:LEB vs PVI的sHR 0.66(95%CI 0.44-0.97,P=.04)。
- 5年死亡率:LEB vs PVI的HR 0.79(95%CI 0.71-0.88,P<.001)。
- 5年截肢率:LEB vs PVI的sHR 1.03(95%CI 0.89-1.20,P=.67)。
临床怎么用
- 研究结果可能有助于为CLTI合并CKD患者的LEB与PVI偏好敏感治疗决策提供信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Comorbid chronic kidney disease (CKD) is associated with worse outcomes for patients with chronic limb-threatening ischemia (CLTI). However, comparative effectiveness data are limited for lower extremity bypass (LEB) vs peripheral vascular intervention (PVI) in patients with CLTI and CKD. We aimed to evaluate (1) 30-day all-cause mortality and amputation and (2) 5-year all-cause mortality and amputation for LEB vs PVI in patients with comorbid CKD. METHODS: Individuals who underwent LEB and PVI were queried from the Vascular Quality Initiative with Medicare claims-linked outcomes data. Propensity scores were calculated using 13 variables, and a 1:1 matching method was used. The mortality risk at 30 days and 5 years in LEB vs PVI by CKD was assessed using Kaplan-Meier and Cox proportional hazards models, with interaction terms added for CKD. For amputation, cumulative incidence functions and Fine-Gray models were used to account for the competing risk of death, with interaction terms for CKD added. RESULTS: Of 4084 patients (2042 per group), the mean age was 71.0 ± 10.8 years, and 69.0% were male. Irrespective of CKD status, 30-day mortality (hazard ratio [HR]: 0.94, 95% confidence interval [CI]: 0.63-1.42, P = .78) was similar for LEB vs PVI, but LEB was associated with a lower risk of 30-day amputation (sub-HR [sHR]: 0.66, 95% CI: 0.44-0.97, P = .04). CKD status, however, did not modify these results. Similarly, LEB vs PVI was associated with a lower risk of 5-year mortality (HR: 0.79, 95% CI: 0.71-0.88, P < .001) but no difference in 5-year amputation (sHR: 1.03, 95% CI: 0.89-1.20, P = .67). CKD status did not modify these results. CONCLUSIONS: Regardless of CKD status, patients had a lower risk of 5-year all-cause mortality and 30-day amputation with LEB vs PVI. Results may help inform preference-sensitive treatment decisions on LEB vs PVI for patients with CLTI and CKD, who may commonly be deemed too high risk for surgery.
引用
- Cleman J, Sierra JG, Romain G, et al. Comparison of mortality and amputation after lower extremity bypass versus peripheral vascular intervention in patients with chronic limb-threatening ischemia and comorbid chronic kidney disease. J Vasc Surg. 2024. PMID: 38608966. doi:10.1016/j.jvs.2024.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。